Clinical Trial Update: Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ketotifen/naphazoline ophthalmic solution for acute allergic conjunctivitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• ketotifen/naphazoline ophthalmic solution

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2020-10-27